Mechanism of Action and Pharmacological Effects
According to the pharmacological classification, Fluocinolone acetonide belongs to agents regulating metabolic processes. When applied topically, the drug has a targeted effect on tissues, modifying local metabolism directly at the lesion site. Unlike systemic medications, its effects are realized strictly at the site of application, which achieves the necessary therapeutic result in skin pathologies while minimizing the overall systemic impact on the body.
Indications for Use
The primary indication for prescribing fluocinolone acetonide is various conditions in dermatology. The drug is used when there are affected skin areas requiring pharmacological regulation of metabolic processes. In clinical practice, it is used in the form of ointments and creams. Students should remember the best-known trade names of this drug — synaflan and flucinar.
Side Effects and Contraindications
While basic methodological materials do not detail specific systemic side effects, the most critical safety rule is the requirement to apply the ointment exclusively in a thin layer. This strict instruction indirectly indicates the high potency of the drug. Applying a thin layer is necessary to avoid excessive absorption of the active substance and prevent undesirable local or systemic reactions associated with the disruption of metabolic processes.
Prescription Writing and Administration Rules
Fluocinolone acetonide is prescribed strictly for topical (external) use. The prescription reference guide highlights the officinal ointment with an active substance concentration of 0.025%, available in 15 g tubes.
Since the ointment is officinal (its composition and proportions are standardized by the pharmacopoeia), a abbreviated prescription form is used without specifying the ointment base.
Prescription example: ```latin Rp.: Ung. Fluocinoloni acetonidi 0.025% - 15,0 D.S. Apply to affected skin areas in a thin layer. ```
Prescription breakdown:
- `Ung.` (Unguenti) — indication of the dosage form (ointment).
- `Fluocinoloni acetonidi` — international nonproprietary name in the genitive case.
- `0.025% - 15,0` — concentration and total amount of the drug.
- In the signature (`D.S.`), the physician gives clear instructions to the patient on the method of application.
Classification and Comparison with Analogues
Depending on the dosage form and therapeutic goal, fluocinolone acetonide is included in the subgroup of topical agents. It is grouped alongside representatives such as mometasone (Elocom), fluocortolone (Ultralan), and flumethasone (Lorinden).
To successfully solve pharmacology test questions, it is important to clearly distinguish drugs by their application profile. Tests often ask to select a medical specialty (cardiology, gastroenterology, neurology, pulmonology).
Remember the logic:
- Dermatology (topical application): ointments and creams (fluocinolone acetonide and analogues) are used to target the skin.
- Pulmonology (inhalation application): glucocorticoids (GCs) are used to treat bronchial asthma and COPD. Representatives of this group include beclomethasone (Beclomet, Becotide), budesonide (Pulmicort), flunisolide (Ingacort), and fluticasone (Flixotide).
Both groups share the principle of local drug delivery, but they differ cardinally in dosage forms and clinical objectives.